FMP
ALNY icon

Financial Management Professionals’s Alnylam Pharmaceuticals ALNY Stock Holding History

Financial Management Professionals’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-25
Closed -$2K – 286
2018
Q2 		$2K Buy
+25
New +$2.48K ﹤0.01% 233

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Financial Management Professionals's ALNY Position: Q3 2018 in Review

Financial Management Professionals sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2018, closing a stake of 25 shares — an estimated $2K sold.

Financial Management Professionals first reported a position in ALNY in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 305 funds tracked by Wall St. Rank hold ALNY as of Q3 2018.

  • Financial Management Professionals reported no remaining Alnylam Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Financial Management Professionals sold 25 Alnylam Pharmaceuticals shares in Q3 2018, an estimated $2K.
  • Financial Management Professionals first reported a position in Alnylam Pharmaceuticals in Q2 2018 and held it in 1 quarter.
  • Financial Management Professionals's Alnylam Pharmaceuticals position peaked at $2K in Q2 2018.
  • 305 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2018.

Based on Financial Management Professionals's 13F filing for Q3 2018, filed 24 Oct 2018.